期刊文献+

基于年龄与氨基酸比例构建的Logistic回归分析模型诊断乙型肝炎相关肝纤维化程度的效能评价 被引量:2

Diagnosis of hepatic fibrosis in hepatitis B patients by logistic regression modeling based on plasma amino acid ratio and age
暂未订购
导出
摘要 目的探讨基于年龄和氨基酸比例模型构建的Logistic回归模型诊断乙型肝炎相关肝纤维化程度的效能。方法 148例经肝活组织检查的慢性乙型肝炎患者入选本研究。病理学分期≥S2、≥S3和=S4分别被定义为显著、严重和进展期肝纤维化。血浆氨基酸测定采用Agilent1100系列高效液相色谱仪,血浆氨基酸比例模型通过建立分数函数的方式构建。根据部分变量组合构建的比例模型数量较大,本文只选择与病理学分期有显著相关性的相关系数由大到小排列的前6个比例模型进行分析。基于年龄和氨基酸比例模型构建的Logistic回归模型诊断肝纤维化程度的效能评价采用受试者工作特征曲线(ROC曲线)法。结果基于年龄和氨基酸比例模型构建的诊断显著肝纤维化的Logistic回归模型不成立。基于年龄和氨基酸比例模型构建的诊断严重肝纤维化的Logistic回归模型的预测概率(PPsev)诊断严重肝纤维化的ROC曲线下面积为0.722,95%CI为0.640~0.804;基于最佳截断值的PPsev诊断严重肝纤维化的灵敏度、特异度、准确度分别为0.49、0.85、0.69。基于年龄和氨基酸比例模型构建的诊断进展期肝纤维化的Logistic回归模型的预测概率(PPadv)诊断进展期肝纤维化的ROC曲线下面积为0.792,95%CI为0.708~0.876;基于最佳截断值的PPadv诊断进展期肝纤维化的灵敏度、特异度、准确度分别为0.73、0.76、0.75。结论基于年龄和氨基酸比例模型构建的Lo-gistic回归模型对乙型肝炎相关的严重和进展期肝纤维化有一定诊断价值。 Objective To explore the efficacy of logistic regression modeling based on plasma amino acid profile and patient age,for diagnosing hepatic fibrosis in patients with chronic hepatitis B(CHB).Methods One-hundred-and-forty-eight patients(108 males;mean age: 38.1±11.9 years,range: 16-72 years) histologically diagnosed with CHB at our institute between January 2009 and June 2011 were enrolled for study.Pathological staging of fibrosis classified patients as: significant(≥S2),severe(≥S3),or advanced(S4) stages.Plasma molar concentrations of amino acids were determined by high-performance liquid chromatography,and used to establish the top six fractional ratio models according to progressive significance of correlations with pathological stages(by Spearman′s rank correlation coefficient analysis).The abilities of scale models to predict fibrosis were evaluated using the area under the receiver operating characteristic(AUROC) curve.ROC curve analysis allowed for the best cutoff for age to be determined for the pathological stages and calculation of sensitivity,specificity,and accuracy for the corresponding prediction probabilities(PP).Results Patient age was postively correlated with pathological stage(rs=0.262,P=0.001).The significant correlation coefficients for the six models were(in descending order):(isoleucine+leucine)/tyrosine(rs=-0.350,P=0.000),leucine/tyrosine(rs=-0.349,P=0.000),(isoleucine+leucine+valine)/tyrosine (rs=-0.345,P=0.000),(leucine+valine)/tyrosine(rs=-0.342,P=0.000),(isoleucine+valine)/tyrosine(rs=-0.336,P=0.000),valine/tyrosine (rs=-0.311,P=0.000). The logistic regression model based on age and the ratio models of plasma amino acids could not be established.For severe fibrosis,the PP was 0.722(95% CI: 0.640-0.804),with sensitivity of 0.49,specificity of 0.85,and accuracy of 0.69.For advanced fibrosis,the PP was 0.792(95% CI: 0.708-0.876),with sensitivity of 0.73,specificity of 0.76,and accuracy of 0.75.Conclusion Logistic regression modeling based on plasma amino acid profile and patient age could have clinical utility for sensitive,specific and accurate diagnosis of severe and advanced fibrosis in CHB patients.
出处 《临床肝胆病杂志》 CAS 2013年第5期330-335,共6页 Journal of Clinical Hepatology
基金 上海市科委医学引导类项目(09411965800) 国家"863"高技术研究发展计划生物和医药领域重大/重点基金(2006AA02A411)
关键词 氨基酸类 肝炎 乙型 肝硬化 LOGISTIC模型 amino acids hepatitis B liver cirrhosis Logistic models
  • 相关文献

参考文献2

二级参考文献21

  • 1张占卿,徐伟民,巫善明.乙型肝炎病人性甾体激素变化及其与乙型肝炎病毒复制的相关性[J].世界感染杂志,2004,4(5):437-439. 被引量:8
  • 2Wai CT, Cheng CL, Wee A, et aL Non-invasive models for predicting histology, in patients with chronic hepatitis B [J]. Liver lnt, 2006, 26 ( 6 ) : 666-672.
  • 3Park SY, Kang KH, Park JH, et al. Clinical efficacy of AST/ALT ratio and platet counts as predictors of degree of firosis in HBV infected patients without clinically evident liver cirrhosis [ J]. Korean J Gastroenterol, 2004, 43 (4) : 246-251.
  • 4Wai CT, Greenson JK, Fontana R J, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C [J]. Hepatology, 2003, 38(2): 518-526.
  • 5Imperiale TF, Said AT, Cummings OW, el al. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C [J]. Am J Gastroenterol, 2000, 95(9) : 2328- 2332.
  • 6Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection [ J]. Am J Gastroenterol, 1998, 93( 1 ) : 44-48.
  • 7Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepalitis C [J]. Hepatology, 2005, 41(6) : 1376-1382.
  • 8Giannini E, Testa R. Nonimasive diagnosis of fibrosis: the truth is rarely pure and never simple [ J ]. Hepatology, 2003, 38 (5): 1312-1313.
  • 9Kim BK, Kiln SA, Park YN, et al. Noninvasive models to prediet liver cirthosis in patients with chronic hepatitis B [ J ]. Liver Int, 2007, 27 ( 7 ) : 969-976.
  • 10Shaheen AA, Myers RP. Diagnostic accuracy of tile aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis : a systematic review [ J ]. Hepatology, 2007, 46 ( 3 ) : 912- 921.

共引文献26

同被引文献27

  • 1Wu, Sheng-Di,Wang, Ji-Yao,Li, Lei.Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model:A comparative study[J].World Journal of Gastroenterology,2010,16(4):501-507. 被引量:26
  • 2陈月桥,毛德文.肝纤维化动物模型制备的研究进展[J].实用肝脏病杂志,2007,10(3):205-207. 被引量:8
  • 3Wu J, Norton PA. Animal models of liver fibrosis [J]. Seand J Gas- troenterol, 1996,31 (12) : 1137-1143.
  • 4Hernandez-Munoz R,Diaz-Munoz M,Suarez-Cuenca JA,et al. Adenosine reverses a preestablished CC~-induced micronodular cir- rhosis through enhancing collagenolytic activity and stimulating hepa- tocyte cell proliferation in rats [J]. Hepatology ,2001,34(4) :677-687.
  • 5Roderfeld M,Geier A,Dietrich CG,et al. Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase-1 expression and up- regulates matrixmetallo-proteinase-9 in toxic liver injury [J]. Liver International, 2006,26 (5) : 579-586.
  • 6Henderson NC, Iredale JP. Liver fibrosis : cellularmeehanisms of pro- gression and resolution [J]. Clin Sci, 2007,112 (5):265-280.
  • 7Boeker K H,Haberkorn CI,Michels D,et al. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in pa- tients with chronic hepatitis C [J]. Clin Chim Acta,2002,316 (21): 71-81.
  • 8Eaudll R,BrennerDA. Liver fibrosis [J]. J Clin investing,2005,115 (2) :209-219.
  • 9Rockey DC. Antifibrotic therapy in chronic liver disease [J]. Clin Gaetroenlerol Hepatol, 2005,3 (2) : 95-107.
  • 10张占卿,贾小芳,陆伟,张丽军,丁荣蓉,饶敏,王雁冰,冯艳玲.氨基酸血浆浓度判别慢性乙型肝炎肝组织病理状态的评价[J].中华临床医师杂志(电子版),2012,6(17):5095-5099. 被引量:2

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部